Briviact approved for epileptic seizures
(HealthDay)—Briviact (brivaracetam) has been approved by the U.S. Food and Drug Administration to treat partial onset seizures in people aged 16 and older with epilepsy.
Feb 19, 2016
0
1
(HealthDay)—Briviact (brivaracetam) has been approved by the U.S. Food and Drug Administration to treat partial onset seizures in people aged 16 and older with epilepsy.
Feb 19, 2016
0
1
(HealthDay)—Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat basal cell carcinoma skin cancer that has returned despite surgery or radiation.
Jul 25, 2015
0
12
(HealthDay)—Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat patients with locally advanced basal cell carcinoma that has returned despite surgery or radiation, or who are not candidates ...
Jul 25, 2015
0
14
Two female patients achieved clinical remission from the rare, debilitating neurological disease called stiff person syndrome (SPS, which can be marked by a "tin soldier" gait) after an autologous (from your own body) stem ...
Aug 25, 2014
0
1
(HealthDay)—Lawrence Schmelz spent a lot of time in the gym keeping his body fit—up to two hours a day, every day, at age 50.
Jan 10, 2014
2
0
A prospective study of 23 women aged 21 – 71, reported at the International Neuromodulation Society 11th World Congress, showed pelvic neuromodulation for bladder disorders also increased five of six sexual function scores ...
Jun 12, 2013
0
0
(HealthDay)—The U.S. Food and Drug Administration has approved a new drug to treat postmenopausal women who experience pain during sex, the agency announced Tuesday.
Feb 26, 2013
0
0
There is no strong evidence to back the use of cannabis extract in the treatment of Multiple Sclerosis (MS), concludes a review of the available evidence on the first licensed preparation, published in the December issue ...
Dec 12, 2012
0
0
Commonly prescribed sleeping pills/sedatives may increase the risk of contracting pneumonia by as much as 50% and increase the risk of dying from it, suggests research published online in the journal Thorax.
Dec 5, 2012
0
0
Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.
Feb 13, 2012
0
0